TipRanks
Advertisement
Advertisement

GNNSF Stock Latest News

Genscript Biotech Halves Trading Lot Size to Boost Liquidity on Hong Kong Market
Company AnnouncementsGenscript Biotech Halves Trading Lot Size to Boost Liquidity on Hong Kong Market
9d ago
Genscript Biotech Joins Lilly’s AI Drug Discovery Platform Amid Share Price Surge
PremiumCompany Announcements
Genscript Biotech Joins Lilly’s AI Drug Discovery Platform Amid Share Price Surge
13d ago
Genscript Biotech Reshapes Board Committees After Director’s Passing
PremiumCompany Announcements
Genscript Biotech Reshapes Board Committees After Director’s Passing
14d ago
Genscript Biotech Details Board and Committee Structure in Governance Update
PremiumCompany Announcements
Genscript Biotech Details Board and Committee Structure in Governance Update
14d ago
Genscript Biotech Raises HK$2.33 Billion Through Hong Kong Share Placing
PremiumCompany Announcements
Genscript Biotech Raises HK$2.33 Billion Through Hong Kong Share Placing
15d ago
Genscript Biotech to Raise HK$2.33 Billion via Discounted Share Placing for AIDD Expansion
PremiumCompany AnnouncementsGenscript Biotech to Raise HK$2.33 Billion via Discounted Share Placing for AIDD Expansion
19d ago
GenScript Biotech Updates Cayman Islands Corporate Service Provider Names
Premium
Company Announcements
GenScript Biotech Updates Cayman Islands Corporate Service Provider Names
23d ago
Genscript Plans Hong Kong Spin-Off Listing for Probio Technology
Premium
Company Announcements
Genscript Plans Hong Kong Spin-Off Listing for Probio Technology
26d ago
Genscript Biotech Earnings Call Signals AI‑Driven Upswing
PremiumCompany Announcements
Genscript Biotech Earnings Call Signals AI‑Driven Upswing
1M ago
Genscript Biotech Clarifies Board Structure and Committee Roles
PremiumCompany Announcements
Genscript Biotech Clarifies Board Structure and Committee Roles
1M ago
Genscript Biotech Posts Strong Core Growth but Reports Interim Loss on Legend Impact
PremiumCompany Announcements
Genscript Biotech Posts Strong Core Growth but Reports Interim Loss on Legend Impact
1M ago
Genscript Highlights Legend Biotech’s Q2 Results and Cautions Investors
PremiumCompany Announcements
Genscript Highlights Legend Biotech’s Q2 Results and Cautions Investors
2M ago
Genscript Biotech Sets August Board Meeting to Approve Interim Results
PremiumCompany AnnouncementsGenscript Biotech Sets August Board Meeting to Approve Interim Results
2M ago
Genscript Highlights Strong CARVYKTI Sales via Legend Biotech, Urges Investor Caution
Premium
Company Announcements
Genscript Highlights Strong CARVYKTI Sales via Legend Biotech, Urges Investor Caution
3M ago
GenScript Associate Legend Biotech Reports Promising In Vivo CAR-T Data in B-Cell Lymphoma
Premium
Company Announcements
GenScript Associate Legend Biotech Reports Promising In Vivo CAR-T Data in B-Cell Lymphoma
4M ago
Genscript Biotech Shareholders Approve All Resolutions at 2026 AGM
PremiumCompany Announcements
Genscript Biotech Shareholders Approve All Resolutions at 2026 AGM
4M ago
Genscript Biotech Grants 14.7 Million RSUs to Strengthen Long-Term Incentives
PremiumCompany Announcements
Genscript Biotech Grants 14.7 Million RSUs to Strengthen Long-Term Incentives
4M ago
Genscript Highlights Legend Biotech’s Early In Vivo CAR-T Data for B-Cell Lymphoma
PremiumCompany Announcements
Genscript Highlights Legend Biotech’s Early In Vivo CAR-T Data for B-Cell Lymphoma
4M ago
Genscript Highlights Legend Biotech’s New CAR-T Data in Oncology Programs
PremiumCompany Announcements
Genscript Highlights Legend Biotech’s New CAR-T Data in Oncology Programs
4M ago
GenScript Associate Legend Biotech to Unveil New CAR-T Data at 2026 ASCO Meeting
PremiumCompany AnnouncementsGenScript Associate Legend Biotech to Unveil New CAR-T Data at 2026 ASCO Meeting
4M ago
Genscript flags Legend Biotech Q1 results and cautions investors on risk
Premium
Company Announcements
Genscript flags Legend Biotech Q1 results and cautions investors on risk
5M ago
Genscript Highlights Strong Q1 2026 CARVYKTI Sales via Legend Biotech
Premium
Company Announcements
Genscript Highlights Strong Q1 2026 CARVYKTI Sales via Legend Biotech
6M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >